T

Treeline Biosciences

Biotech firm discovering cancer therapies.

Associate Director / Director - Nonclinical Toxicology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSan Diego, CA, USA$207k - $243.3k /yrIn-person

About the Job

Requirements

  • A master's, Ph.D., DVM, or advanced degree in Toxicology, Pharmacology, Veterinary Medicine, or a related biomedical science, or equivalent experience.
  • Five to ten years of relevant toxicology experience in pharmaceutical, biotech, or CRO settings.
  • Demonstrated experience writing and reviewing toxicology study plans, protocols, and final study reports.
  • Direct experience managing or interfacing with CROs conducting in-life toxicology studies.
  • Experience serving as Study Monitor on GMP toxicology studies, including in-life visits, protocol and report review, and direct communication with CRO study directors.
  • Working knowledge of study budgets, including reviewing CRO quotes and change orders, tracking spend against budget, and flagging scope or cost deviations to project teams.
  • Solid understanding of GMP regulations, ICH guidelines such as M3(R2), S9, and S6, and FDA/EMA nonclinical safety expectations.
  • Demonstrated experience contributing toxicology content to IND submissions or CTA equivalents, including authoring nonclinical written summaries and supporting health authority interactions.
  • Ability to clearly convey complex scientific concepts to cross-functional and non-toxicology audiences.
  • Proven ability to manage multiple projects and timelines in a fast-paced, deadline-driven environment.

Responsibilities

  • Author, review, and finalize toxicology study protocols, amendments, and study reports with CRO partners, ensuring scientific rigor and regulatory compliance.
  • Interface directly with CROs to scope, place, monitor, and troubleshoot in-life toxicology studies, including dose range-finding, repeat-dose, safety pharmacology, and specialized studies as needed.
  • Serve as Study Monitor for in-life toxicology studies, including on-site or virtual monitoring visits, real-time issue resolution, and direct follow-up with CRO study directors to keep studies on track.
  • Own budget tracking and oversight for assigned studies by reviewing CRO quotes and change orders, monitoring spend against forecast, and flagging deviations to project teams and finance.
  • Review and interpret toxicology data, including clinical pathology, histopathology, and TK/PK, to assess safety signals and inform risk assessment and dose selection.
  • Author and contribute toxicology sections for IND or CTA submissions, Investigator's Brochures, and briefing documents, and support responses to health authority questions.
  • Partner with DMPK, pharmacology, CMC, and clinical teams to integrate toxicology findings into overall program risk/benefit assessments.
  • Track study timelines, budgets, and deliverables across multiple concurrent CRO-run studies; escalate risks and resolve issues proactively.
  • Stay current with FDA, ICH, and EMA regulatory guidance and industry best practices in toxicology and nonclinical safety assessment.
  • Serve as toxicology representative and strategic partner on multidisciplinary project teams, providing scientific input on nonclinical safety strategy from discovery through IND/CTA filing and beyond.

Desired Qualifications

  • DABT (Diplomate, American Board of Toxicology) certification is strongly recommended.
  • Experience across multiple modalities, including small molecules, biologics, and ADCs.
  • Prior experience in a sponsor-side role managing external vendor relationships.
  • Experience presenting toxicology data to internal governance committees or health authorities.
  • Experience with Veeva or other document management systems.

About the Company

Treeline Biosciences

Biotech firm discovering cancer therapies.

Treeline Biosciences develops proprietary therapies for cancer and other serious diseases by conducting in-depth R&D across biology, chemistry, protein sciences, and computational science. Its product work involves discovering and optimizing drug candidates, then licensing these therapies to larger pharmaceutical companies or selling them to healthcare providers, with support from CRO collaborations to speed development. The company differentiates itself through a balanced mix of in-house research and external partnerships, a robust IP strategy, and a team that blends experienced biotech veterans with new talent, all backed by funding from KKR to scale operations. Its goal is to build a sustainable, long-term pipeline of treatments that can reach patients while expanding capabilities and partnerships in the biotech ecosystem.

Company size
51-200
Company stage
Series A
Total funding
$1.1B
Headquarters
Stamford, CT
Founded
2021

Recently Posted Jobs

Explore more opportunities at Treeline Biosciences

See more jobs